• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,298.76 50.34
(0.81%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,823.20 48.51
(0.55%)
Forex
USD-INR
85.63 0.05
(0.05%)
EUR-INR
100.93 0.01
(0.01%)
GBP-INR
117.11 -0.50
(-0.43%)
JPY-INR
0.60 0.00
(-0.16%)

EQUITY - MARKET SCREENER

Genpharmasec Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
531592
INE861N01036
1.2019072
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
51.5
114.07
EPS(TTM)
Face Value()
Div & Yield %
0.04
1
0
 

sanofi india ltd
Ind-Swift consolidated net profit rises 583.54% in the March 2025 quarter
Jun 26,2025
Net profit of Ind-Swift rose 583.54% to Rs 256.60 crore in the quarter ended March 2025 as against Rs 37.54 crore during the previous quarter ended March 2024. Sales rose 7.15% to Rs 144.90 crore in the quarter ended March 2025 as against Rs 135.23 crore during the previous quarter ended March 2024.

For the full year,net profit rose 1891.92% to Rs 283.45 crore in the year ended March 2025 as against Rs 14.23 crore during the previous year ended March 2024. Sales rose 2.58% to Rs 515.23 crore in the year ended March 2025 as against Rs 502.25 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales144.90135.23 7 515.23502.25 3
OPM %-1.9910.86 -4.469.73 -
PBDT-4.4146.27 PL 31.4439.16 -20
PBT-11.5939.39 PL 7.9412.05 -34
NP256.6037.54 584 283.4514.23 1892